Ignite Creation Date:
2024-05-06 @ 3:49 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04768114
Status:
COMPLETED
Last Update Posted:
2024-01-03
First Post:
2021-02-11
Brief Title:
Implementation of Genomics in Substance Use Disorder Treatment
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Study Overview
Official Title:
Toward the Implementation of Genomics in Substance Use Disorder Treatment
Status:
COMPLETED
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Cigarette smoking remains one of the leading causes of preventable death Effective smoking cessation medications exist but use of these treatments is low making it difficult for most to quit smoking Behavioral interventions are needed to engage current smokers in the process of quitting smoking and promote the use of evidence-based cessation medications
At the same time genetics influences ones smoking behaviors eg how much they smoke difficulty quitting and risk of smoking-related diseases yet these personalized factors have not been included in existing behavioral interventions Incorporating these individualized factors into smoking cessation interventions may make them more personally engaging and thus motivating for treatment
This study will pilot test a risk communication tool that is personalized to ones genetics and will demonstrate the feasibility of a larger trial to test the effect of this personalized genetically-informed intervention on smoking cessation
At the same time genetics influences ones smoking behaviors eg how much they smoke difficulty quitting and risk of smoking-related diseases yet these personalized factors have not been included in existing behavioral interventions Incorporating these individualized factors into smoking cessation interventions may make them more personally engaging and thus motivating for treatment
This study will pilot test a risk communication tool that is personalized to ones genetics and will demonstrate the feasibility of a larger trial to test the effect of this personalized genetically-informed intervention on smoking cessation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| K12DA041449 | NIH | None | httpsreporternihgovquickSearchK12DA041449 |